Sorrento Therapeutics gets approval of some first-day motions

By Sarah Lizee

Olympia, Wash., Feb. 16 – Sorrento Therapeutics, Inc. has received approval of its employee wages and cash management first-day motions from the U.S. Bankruptcy Court for the Southern District of Texas, according to a press release issued Thursday.

The company said it expects to seek approval of other first-day motions in the coming days.

The biopharmaceutical company is based in San Diego. The company filed bankruptcy on Feb. 13 under Chapter 11 case number 23-90085.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.